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In the cytoplasm, the correct delivery of membrane
proteins is an essential and highly regulated process.
The posttranslational targeting of the important tail-
anchor membrane (TA) proteins has recently been
under intense investigation. A specialized pathway,
called the guided entry of TA proteins (GET) pathway
in yeast and the transmembrane domain recognition
complex (TRC) pathway in vertebrates, recognizes
endoplasmic-reticulum-targeted TA proteins and
delivers them through a complex series of handoffs.
An early step is the formation of a complex between
Sgt2/SGTA, a cochaperone with a presumed ubiqui-
tin-like-binding domain (UBD), and Get5/UBL4A,
a ubiquitin-like domain (UBL)-containing protein.
We structurally characterize this UBD/UBL interac-
tion for both yeast and human proteins. This charac-
terization is supported by biophysical studies that
demonstrate that complex formation is mediated
by electrostatics, generating an interface that has
high-affinity with rapid kinetics. In total, this work
provides a refined model of the interplay of Sgt2
homologs in TA targeting.
INTRODUCTION
Two homologous pathways have been elucidated for the target-
ing of tail-anchor membrane (TA) proteins to the endoplasmic
reticulum (ER) (recently reviewed in Chartron et al., 2012a; Denic,
2012; Hegde and Keenan, 2011). The best characterized is the
fungal guided entry of TA proteins (GET) pathway. In its simplest
form, a TA sorting complex comprising Sgt2, Get4, and Get5
(alternatively named Mdy2) facilitates the loading of a TA sub-
strate onto the Get3 ATPase. The Get3/TA complex is targeted
to the ER, where the TA is released for insertion by the
membrane proteins Get1 and Get2. Vertebrates have a related
system, referred to as the transmembrane domain recognition
complex (TRC) pathway. In this case, the sorting complex simi-
larly contains the proteins TRC35 and UBL4A (alternatively
named GDX), homologs of Get4 and Get5, respectively; how-
ever, they form a three-component complex with the protein
BAG6 (alternatively named BAT3 or Scythe) that is referred to1620 Cell Reports 2, 1620–1632, December 27, 2012 ª2012 The Autas the BAG6 complex. From here, the TA is handed to a Get3
homolog, TRC40, that delivers the protein to WRB, a homolog
of Get1.
Sgt2, a heat-shock protein (HSP) cochaperone, facilitates the
first committed step in TA protein targeting. It has been linked
genetically and physically to the GET pathway in multiple studies
(Battle et al., 2010, Costanzo et al., 2010; Liou et al., 2007; Wang
et al., 2010). It recruits a variety of HSP families via an internal
tetratricopeptide repeat (TPR) domain (Chartron et al., 2011;
Wang et al., 2010). The Sgt2 C-terminal domain can bind to
sequences of six or more hydrophobic residues (Liou and
Wang, 2005). This includes the transmembrane domain of
ER-destined TA proteins that are subsequently transferred to
Get3, a process that requires the Get4/Get5 complex (Wang
et al., 2010). Mitochondrial TA proteins, which can also copurify
with the Sgt2/Get4/Get5 complex, are associated with bound
HSPs and are not transferred to Get3 (Wang et al., 2010). The
role of Sgt2 in sorting between target organelles is supported
by the mislocalization of ER resident TA proteins to the mito-
chondria in Dsgt2 cells (Costanzo et al., 2010). The C-terminal
domain, which is rich in asparagine, glutamine, and methionine,
contains only a short conserved sequence and is weakly pre-
dicted as helical. A small N-terminal homodimerization domain
(Sgt2-N) mediates the association with a single copy of Get5,
providing the link to the rest of the GET pathway (Kohl et al.,
2011; Chang et al., 2010; Chartron et al., 2011; Liou et al.,
2007). By immunoprecipitation from yeast lysate, the majority
of Get5 is associated with Sgt2 (Wang et al., 2010).
Get4 andGet5 form the adaptor that is required for the transfer
of TA proteins from Sgt2 to Get3 (Wang et al., 2010). Get4 forms
a complex with the N-terminal domain of Get5 and sequesters
a nucleotide-bound Get3 (Bozkurt et al., 2010; Chang et al.,
2010; Chartron et al., 2010). Get5 has a central ubiquitin-like
domain (Get5-UBL) that binds Sgt2-N, and a C-terminal homo-
dimerization domain, resulting in an extended Get4/Get5 heter-
otetrameric complex (Chartron et al., 2010, 2012b). The complex
between Get5 and Sgt2 can be disrupted in vitro by a pair of
mutations to the UBL domain that also lead to incomplete rescue
of Dget5 growth defects under stress conditions (Chartron et al.,
2010). Moreover, the TA protein transfer reaction is competed
by excess Get5, which cannot alone form a productive complex
with Get3 (Wang et al., 2010). These results underscore the
importance of the physical interaction between Sgt2 and the
Get4/Get5 complex. The details of the transfer of TA proteins,
including energetic requirements and the in vivo stoichiometryhors
of Sgt2, Get4/Get5, and Get3 over the course of the handoff,
remain to be established.
SGTA, the human homolog of Sgt2, associates with the BAG6
complex through its N terminus (Winnefeld et al., 2006), and
UBL4A is postulated to bridge this interaction (Chartron et al.,
2012a; Hegde and Keenan, 2011). The BAG6 complex is
required for loading TA proteins onto TRC40 (Leznicki et al.,
2010; Mariappan et al., 2010), and is also involved in the degra-
dation of membrane proteins in the cytoplasm (Hessa et al.,
2011; Minami et al., 2010; Wang et al., 2011).
In this report, we use a combination of structural biology and
biochemistry to define the interaction between Sgt2 and Get5,
which is conserved from yeast to humans. We now present
structures of the N-terminal homodimerization domains from
two homologs, yeast Sgt2 and human SGTA, and characterize
their fold as a new class of UBD. Further, we solve the structure
of the central domain of Get5, demonstrating it as a novel UBL.
Finally, we determined the structure of the complex between an
Sgt2-N homodimer and the Get5-UBL, revealing an interaction
strongly influenced by electrostatics. We used a variety of
methods to demonstrate that this interaction has high affinity
with rapid binding kinetics. This work provides a critical context
for understanding the Sgt2/Get4/Get5 complex, and in addition
describes a mechanism for membrane protein entry in the
seemingly more complicated mammalian system.
RESULTS
Structures of the Sgt2 and SGTA Dimerization Domains
The Sgt2-N domain is both a homodimerization domain and
a binding platform for the Get5-UBL domain. This provides the
physical link between the Sgt2 chaperone complex and the
GET pathway. Sgt2-N does not have sequence homology to
any known structures or other characterized UBDs. To under-
stand how these dual functions are accomplished, we first
determined the structure of the Saccharomyces cerevisiae
Sgt2-N homodimer using solution nuclear magnetic resonance
(NMR). The statistics for the NMR structure calculations are
provided in Table S1. A monomer of Sgt2-N consists of three
helices (Figures 1A–1C). The first two helices are of similar length
and mediate homodimerization, forming a four-helix bundle with
2-fold symmetry, consistent with the postulated coiled-coil
(Tobaben et al., 2003). A third, shorter helix packs against either
side of the bundle away from the dimer interface. The residues
C-terminal to this helix, which form the linker to the TPR domain,
give weaker signals than the helical region in all NMR experi-
ments, and therefore only partial chemical shift assignments
were possible. This is due to different rates of motion relative
to the rest of the protein, rather than to proteolysis, as signals
for the terminal residues are observed. The few nuclear Over-
hauser effect (NOE)-derived contacts observed in this sequence
restrain it in partially folded conformations (Figure 1C).
The symmetry axis places the equivalent helices from each
subunit head to tail, resulting in two unique surfaces. We
designate the surface composed of the a2 helices as the
‘‘Get5 binding surface,’’ and the opposite surface, composed
of the a1 helices, as the ‘‘a1 surface’’ (Figures 1B, 1C, S1A,
and S1B). The dimer contacts between a2 helices are made byCell Reconserved small residues (Ser32, Ala36, Cys39, and Ala43),
resulting in close packing between the main chains of the two
subunits (Figure 1B). Cys39 and Val35make a small hydrophobic
patch at the center of the Get5-binding surface (Figures 1A and
1D). The partially exposed Cys39 is strictly conserved across
eukaryotes, and Val35 is fully solvent exposed, conserved as
either valine or isoleucine (Figure 1G). Despite the close prox-
imity of the Cys39 sulfhydryl groups (5.3 ± 0.4 A˚ sulfur-sulfur
distance), the Cb shifts of 27.819 ppm argue against disulfide
bond formation, even after incubation for several months
(Sharma and Rajarathnam, 2000). The conserved acidic residues
Asp28 andGlu31 and the conserved positioning of Glu42, Glu47,
and Glu49 result in a negatively charged ring surrounding the
hydrophobic patch (Figures 1A and 1E).
The dimer contacts between a1 helices are held farther apart
than the a2 helices by the interlocking of large hydrophobic side
chains (Figures 1B and S1A). This results in an exposed hydro-
phobic face at the a1 surface that is protected from solvent, to
some extent, by the partially folded carboxyl terminal linker
(Figures 1C and S1B). When an Sgt2-N variant with this linker
deleted is purified, it forms a higher order oligomer, likely due
to aggregation at this face (data not shown).
We also investigated the N-terminal domain of human SGTA
(SGTA-N). The domain was coexpressed and purified with an
affinity-tagged UBL domain of UBL4A (UBL4A-UBL), demon-
strating a complex that could be separated from excess
UBL4A (Figure S1C). We attempted to crystallize this complex;
however, in the three resulting distinct crystal structures, only
density for SGTA-N was observed. We determined the struc-
tures by molecular replacement using Sgt2-N at 1.35–1.45 A˚
resolutions. The structures differ predominantly by a postpurifi-
cation oxidation of the conserved cysteine with buffer compo-
nents (Figures S1E and S1F). Crystallographic data collection
and refinement statistics are provided in Table S2. SGTA-N
shares the four-helix bundle topology with Sgt2-N (Figure 1F).
As expected from the Sgt2-N solution data, the cysteine sulfhy-
dryl groups do not form a disulfide bond between subunits.
Aswas the case for structures of the Sgt2/SGTA-TPR domains
(Chartron et al., 2011; Dutta and Tan, 2008), Sgt2-N and SGTA-N
have very similar architecture with an rmsd of 1.24 ± 0.07 A˚ over
equivalent Ca atoms (Figure 1F). The sequences have high
homology (Figure 1G) and all of the general features are con-
served, including the hydrophobic patch surrounded by charge
at the binding face (Figures 1F and S1D). One difference is that
SGTA-N does not have a third a-helix. The residues that would
correspond to a3 are disordered or involved in nonphysiological
crystallographic contacts.
Structure of the Get5-UBL Domain
The solution NMR structure of the UBL4A-UBL domain showed
that it has the expected ubiquitin fold (Figure 2A; PDB ID: 2DZI;
RIKEN Structural Genomics Initiative). Get5-UBL has several
small sequence insertions, suggesting some structural differ-
ences (Figure 2F); therefore, to fully characterize the yeast
system, we determined the structure of the Get5-UBL domain.
Initially, we solved a structure by solution NMR (Figure S2A).
Simultaneously, we obtained crystals of Get5-UBL that dif-
fracted to 2.4 A˚ resolution. We were able to obtain phases byports 2, 1620–1632, December 27, 2012 ª2012 The Authors 1621
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Figure 1. Atomic Structure of the Sgt2-N/SGTA-N Dimerization Domain
(A) Solution NMR structure of S. cerevisiae Sgt2-N oriented to show the Get5-binding surface. The cartoon diagram of a representative structure is color ramped
from the N to C terminus (blue to red) for each subunit of the dimer. Conserved residues are shown as sticks with noncarbon atoms colored.
(B) Similar to (A), rotated 90 forward looking down the bundle axis. The locations of the Get5 binding and a1 surfaces are indicated. Interior small (magenta) and
bulky (gray) residue side chains are highlighted as sticks, with hydrogens removed for clarity.
(C) Ribbon diagram of the overlaid ensemble of the ten lowest-energy NMR structures rotated 90 to the right relative to (B). One subunit is color ramped and one
is in gray.
(D) Surface representation of the binding face highlighting exposed hydrophobicity. The surface is color ramped from 0 (gray) to 4.5 (green) on the Kyte-Doolittle
hydrophobicity scale (Kyte and Doolittle, 1982).
(E) Surface representation of the binding face showing the surface charge. The surface is color ramped based on electrostatic potential colored from negative
(red) to positive (blue).
(F) X-ray crystal structure of human SGTA-N aligned to Sgt2-N (gray), similar to (A).
(G) Sequence alignment of Sgt2-N homologs. The species are S. cerevisiae (Scr), Aspergillus fumigatus (Afum), Drosophila melanogaster (Dmel), and Homo
sapiens (Hsap). Alignment and residue coloring are based on the ClustalX output (Larkin et al., 2007). Numbering and secondary structure (rectangles for helices)
are indicated above or below the corresponding sequence. Mutations tested in Figure 3 are highlighted in the numbers colored based on effect.
See also Figure S1.molecular replacement using the Get5-UBL solution structure.
Three copies of Get5-UBL were present in the asymmetric unit
(Figures 2B and S2B). They have an average root-mean-square
deviation (rmsd) of 0.75 A˚ over main-chain atoms. Statistics for
the solution structure calculations and crystallographic data
collection and refinement are presented in Tables S1 and S2,
respectively. The solution and crystal structures are very similar,
with an average main-chain rmsd of 1.23 A˚ (Figure S2A) and
with most variation in loops 1 and 5.1622 Cell Reports 2, 1620–1632, December 27, 2012 ª2012 The AutAlthough overall the structures from Get5 and UBL4A are
similar, there are a few differences due to insertions (Figure S2C).
Based on the structures and sequences of other animal homo-
logs, Get5-UBL has a two-residue insertion around Pro84 in
loop 1. Pro84 is cis, allowing for a tight turn, and there is no
detectable cis-to-trans isomerization by NMR. There are two
additional insertions in Get5-UBL, His113 in loop 3, and Ala141
that cause a short coil-like turn to extend at the end of loop 6.
Despite these differences, the surface elements on the face ofhors
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Figure 2. Atomic Structure of the Get5-UBL/UBL4A-UBL Domain
(A) Ribbon diagram of the humanUBL4A-UBL domain solution structure (PDB ID: 1DZI). Residues equivalent to those tested in Figure 3 are highlighted as sticks in
(A–C).
(B) X-ray crystal structure of the S. cerevisiae Get5-UBL domain. The cartoon of chain A is color ramped between termini.
(C) Overlay of a representative structure of ubiquitin (red, PDB ID: 1UBQ) is shown as a ribbon diagram with Get5-UBL (light blue).
(D) Surface representation highlighting the exposed hydrophobicity of Get5 and ubiquitin as in Figure 1D.
(E) Surface representation showing the surface electrostatic potential of Get5 and ubiquitin as in Figure 1E.
(F) Sequence alignment of Get5-UBL homologs. Sequences are displayed similarly to Figure 1G. In addition, beta-sheets are shown as arrows, and the residues
equivalent to the important ubiquitin residues Ile44 and Lys48 are labeled. Drer, Danio rerio.
See also Figure S2.the b sheet are conserved between Get5 and UBL4A (Figures 2A
and 2B).
The UBL of Get5 and UBL4A have features that distinguish
them from other UBLs with high homology to ubiquitin. UBLs
occur either as independent units known as type I UBLs, which
can be conjugated onto other proteins, or as type II UBLs, which
are domains in larger proteins that frequently mediate binding
to the proteasome (Jentsch and Pyrowolakis, 2000). Get5 falls
into the latter class but does not associate with the 20S protea-
some or polyubiquitin chains (Hu et al., 2006; Saeki et al., 2002).Cell ReTherefore, one would expect that certain features distinguish
Get5 homologs from other UBLs. When we compare Get5-
UBL with ubiquitin, the two most significant structural differ-
ences are the conformations of loop 1 and loop 6 (Figure 2C).
Get5 binds Sgt2 via its UBL through a hydrophobic patch formed
by the conserved Leu120 (Chang et al., 2010; Chartron et al.,
2011), which is equivalent to the conserved Ile44 of ubiquitin
that forms the I44 patch (Hicke et al., 2005). In Get5, the con-
formations of loop 1 and loop 6 significantly reduce the size of
the patch compared with ubiquitin (Figure 2D). Moreover, theports 2, 1620–1632, December 27, 2012 ª2012 The Authors 1623
Figure 3. Importance of Conserved Residues of both Sgt2 and Get5
at the Putative Binding Interface by ITC
The table is a summary of the data obtained by ITC in which mutants were
tested for binding affinity. Mutations tested are colored based on the loss of
binding affinity (red, strong effect; orange, moderate effect; yellow, mild effect;
blue, no significant effect). On the right, mutations are shown colored based on
effect as sticks on a ribbon diagram of Get5-UBL (top) and Sgt2-N (bottom).
See also Figure S3.surface around the I44 patch has a positive charge for both
proteins; however, it is significantly more pronounced in Get5
(Figure 2E).
Characterization of the Putative Interface between
Sgt2-N and Get5-UBL
Wepreviously demonstrated that only a single copy of Get5-UBL
binds to dimeric Sgt2-N, and the double mutation L120A/K122A
prevents complex formation (Chartron et al., 2011). We decided
to probe the interaction further using isothermal titration calorim-
etry (ITC) of wild-type (WT) and mutant proteins (Figures 3 and
S3). All variants behaved similarly to WT during purification
(data not shown). Sgt2-N and Get5-UBL interact with 108 M
affinity independently of which protein is used as a titrant. The
Get5-UBL L120A mutation has a 1,000-fold lower binding
affinity, consistent with the significance of this position in
UBLs. The Get5-UBL L120I mutant bound Sgt2-N with affinity
similar to that of the WT. This is surprising considering that
a leucine at this position is completely conserved, in contrast
to the isoleucine in most UBLs. Mutations of three other nearby
hydrophobic residues that compose part of the hydrophobic
patch (G123Y, V125A, and M147A) also significantly lowered
the binding affinity.
The complementary surface charge of the two proteins
suggests that a significant component of the interaction involves
electrostatics. As expected for this type of binding, affinity dras-
tically decreases as the salt concentration increases. Moreover,
mutations of any of the lysines on this face of Get5-UBL (i.e.,
Lys79, Lys118, Lys122, or Lys124) to alanine reduce the binding
affinity 5- to 10-fold. Interestingly, ubiquitin, which contains most
of the residues tested, binds Sgt2-N with negligible affinity (data
not shown).1624 Cell Reports 2, 1620–1632, December 27, 2012 ª2012 The AutWe made reciprocal mutations to the conserved face of
Sgt2-N and tested their binding to Get5-UBL (Figure 3). Similarly
to Get5, mutation of the two exposed hydrophobic residues to
alanine had the strongest effect with >100-fold lower affinity
(V35A and C39A). The presence of the completely conserved
cysteine was curious. We decided to make a series of typically
minimal changes at this position to test for their effect on
complex formation. A slightly bulkier hydrophobic side chain,
C39V, resulted in a 100-fold lower affinity, whereas removing
the sulfhydryl to a smaller amino acid, C39A, resulted in a nearly
300-fold lower affinity. The strongest effect was conversion of
the sulfhydryl to the more-polar hydroxyl, C39S, which resulted
in a 700-fold lower affinity. Alanine mutations of the acidic
residues that comprised the charged face had a similar effect
on affinity compared with mutations of the basic residues of
Get5-UBL. One exception was mutation of the peripheral
Glu47, located at the beginning of a3, which had no effect on
affinity.
Characterization of the Binding Kinetics of Sgt2-N
and Get5-UBL
Multiple lines of evidence demonstrate complex formation
between Get5 and Sgt2 (Chang et al., 2010; Chartron et al.,
2011; Liou et al., 2007; Wang et al., 2010), and the complex
formed by the minimal Get5-UBL and Sgt2-N domains appears
stable by size exclusion chromatography. The ITC results
suggest that the complex has high affinity; however, investiga-
tions using coimmunoprecipitation have shown variable
amounts of Sgt2 or SGTA associated with the Get5/UBL4A
partners. Although there are many possible reasons for this
variability in stoichiometry in vivo, we hypothesized that fast
binding kinetics could explain how coprecipitation might be
dependent on experimental conditions. To measure the associ-
ation and disassociation rate constants, we turned to surface
plasmon resonance (SPR). In this experiment, polyhistidine-
tagged Get5-UBL or Get5-UBL-C was immobilized and Sgt2-N
was used as the analyte (Figure 4A). Get5-UBL-C includes the
C-terminal dimerization domain of Get5, which is separated
from the UBL domain by a flexible linker (Chartron et al., 2010).
We previously demonstrated that the less-restrictive Get5-
UBL-C dimer can bind two Sgt2-N domains (Chartron et al.,
2011); therefore, we expected that each subunit would act inde-
pendently. The proteins were well behaved on the chip, giving
stable, concentration-dependent saturation (Figure 4B). The
rapid saturation of response after analyte injection (<1 s) and
then rapid reduction after the injection was stopped are indica-
tive of fast on- and off-rates, consistent with our hypothesis.
We calculated the equilibrium dissociation constant by plot-
ting response units as a function of Sgt2-N concentration after
the response units reached equilibrium (Figures 4B–4D). For
Get5-UBL-C, the plot fit to a Kd of 7.49 3 10
7 M. Compared
with ITC, this is nearly two orders of magnitude lower affinity.
Although the different techniques are not expected to give iden-
tical results, due to the different experimental conditions used,
the relative results from mutants are consistent. We suspect
that steric constraints based on interactions with the antibody
affected the measured rates. This was seen when we used
immobilized Get5-UBL, which is expected to bring the Sgt2hors
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Figure 4. Binding is Characterized by Rapid On- and Off-Rates
Mediated by Electrostatics
(A) Scheme used for SPR analysis. Either His-tagged Get5-UBL (UBL-6His) or
Get5-UBL-C (UBL-C-6His) was attached to an anti-6xHis antibody sparsely
immobilized on a CM-5 chip. Sgt2-N was flowed over the chip at varying
concentrations.
(B) Representative SPR experiment flowing varying concentrations of Sgt2-N
over immobilized Get5-UBL-C. Inset: The first 2 s of the experiment, used to
derive ks for Figure 4E.
(C) Plot of equilibrium response units versus concentration of Sgt2-N for
calculation of equilibrium Kd.
(D) Table of the effects of mutants and salt concentration on binding. An
asterisk indicates the experiment performed in triplicate.
(E) Plot of the coefficient that fits ks versus Sgt2-N concentration. The slope
gives the association constant (ka), and the Y intercept gives the dissociation
rate (koff). Error bars represent 1 SD.
Cell Rebinding face into closer proximity to the immobilizing antibody.
This setup had consistently lower binding affinities; for example,
WT binding was further reduced 5-fold to a Kd of 3.783 10
6 M.
Mutants in Sgt2-N or Get5-UBL showed similar changes
in binding affinity compared with ITC. The charged mutants
Get5-UBLK124A, Sgt2-ND28A, and Sgt2-ND31A all had similar
affinities that were on the order of 3- to 4-fold weaker than that of
the WT protein. Also, residues in the hydrophobic interface had
the strongest effect, reducing the affinity of Get5-UBL L120A
or Sgt2-N C39A to below what could be accurately determined
in this experimental setup.
The importance of charge complementarity is consistent with
two preformed interfaces that are electrostatically steered
toward complex formation. These types of protein interactions
are known to have fast binding kinetics (Sheinerman et al.,
2000). Here, we used the association phase of the SPR data to
determine a kon of 1.06 3 10
7 M1 s1 and a dissociation rate
constant of 4 s1 (Figure 4E). The dissociation rate constant
could be independently estimated from the equilibrium Kd and
kon values, which gives an approximate koff of 7.9 s
1. Consistent
with both the electrostatic mechanism and the ITC data,
increasing the salt concentration from 100 to 300 mM salt
resulted in nearly an order of magnitude change inKd (Figure 4D).
All of these data point to a highly specific interface that has rapid
on- and off-rates.
For independent verification of the kinetics, we measured the
exchange rates by NMR using exchange spectroscopy (EXSY;
Perrin and Dwyer, 1990). A 2:1 ratio of 15N-labeled Get5-UBL
to unlabeled Sgt2-N homodimer was prepared, allowing detec-
tion of approximately equimolar free and complex forms of
Get5-UBL. The complex dissociated and reformed within the
timescale of the experiment (mixing time, tm, = 60 or 120 ms).
As a result, exchange cross peaks were observed for every
proton that had a change in chemical shift between the two
states of Get5-UBL (Figures 4F and S4A). The side-chain amide
protons of Gln82 and the main-chain amide protons of Val125,
Asn129, Met147, Ile148, and Lys149 produced exchange peaks
with enough resolution for volume integration. The magnitudes
of these peaks were used to calculate the exchange rates
(Figure S4B). Overall exchange rates of 7.5 ± 2.5 s1 (tm =
60 ms) or 5.7 ± 2.4 s1 (tm = 120 ms) were obtained and
represent koff,NMR. Using the ITC-derived Kd of 34 nM, kon,NMR
is2.03 108M1 s1, which is 20-fold faster than that measured
by SPR. Because the solution and immobilized Get5 off-rates
are similar, the lower binding affinity seen by Get5 immobilization
in the SPR experiment is from a slower kon. Finally, a high-affinity
complex with fast kinetics is consistent the single peak seen by
size exclusion chromatography (Stevens, 1989).
Structure of the Sgt2-N and Get5-UBL Complex
Compared with the proteins alone, the NMR spectra of the
Sgt2-N/Get5-UBL complex have a dramatic reduction in(F) Plot of a 15N plane from an EXSY-HSQC spectrum showing a side-chain
amide proton of Gln82 in free or complex Get5-UBL. The cross peaks indicate
exchange between the two states within the timescale of the experiment.
Similar plots for main-chain protons are provided in Figure S4A.
See also Figure S4.
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Figure 5. Solution Structure of the Sgt2-N/Get5-UBL Complex
(A) Plots of the change in chemical shifts of the 1H-15N HSQC as a combined CSP upon complex formation for each residue at 25C. Changes for residues in gray
could not be accurately determined due to cross-peak overlap. For Sgt2-N, several residues were split into two peaks, breaking the symmetry. These are
indicated in red.
(B) Cartoon representation of Sgt2-N illustrating regions of chemical shift change between the free protein and the complex (cyan). Coloring is based on values
from (A). Residues are color ramped from the smallest (yellow) to the largest (red) CSP. Residues that could not be measured are shown in gray. Residues with
split chemical shifts upon complex formation are shown as green sticks.
(C) Cartoon representation of Get5-UBL, similar to (B).
(D) Representative intermolecular NOEs from a 13C-edited NOESY-HSQC spectrum at 37C constrained to be <6 A˚ away during docking. Peaks identified
as intermolecular are highlighted by a blue arrowhead and labeled. The red question mark represents a peak that is unresolvable from an expected intra-
molecular NOE.
(E) Overlay of the ten best-scored models obtained after NOE-, AIR-, and RDC-driven docking.
(F and G) Two views of the binding interface. In (F), residues determined to interact by ITC are highlighted as sticks. In (G), residues at the interface are drawn as
sticks with the following color scheme: blue, positive; red, negative; orange, polar; yellow, hydrophobic.
See also Figure S5.resolution. This is a result of peak broadening due to both
slower tumbling and the fast kinetics of complex formation
and dissociation. Therefore, instead of generating a uniformly
13C/15N-labeled sample of 235 residues, we opted to investi-
gate two asymmetrically labeled complexes to reduce the
amount of chemical shift overlap. Chemical shift perturbations
(CSPs) on the two-dimensional (2D) 1H-15N heteronuclear single
quantum coherence (HSQC) spectra were examined for both
proteins (Figure 5A). On Sgt2, the most drastic CSPs occurred
at the Get5 binding surface, with very little change occurring in
the rest of the protein (Figure 5B). Binding of a single Get5-UBL
is anticipated to break the symmetry of Sgt2-N, and indeed
several residues on the Get5 binding surface split into two
cross peaks with reduced peak height (Figures 5A and S5A).
Residues without perturbation maintained a single cross
peak, indicating that symmetry remained away from the binding1626 Cell Reports 2, 1620–1632, December 27, 2012 ª2012 The Autsite. The Get5-UBL domain was more broadly affected by
binding to Sgt2-N, but the most intense CSPs occurred at
Ile81 and the loop consisting of residues 123–129, including
Gly123 and Val125.
Inspection of NOE spectroscopy (NOESY) spectra failed to
conclusively identify enough new cross peaks resulting from
intermolecular contacts to determine the structure by NOE
distance restraints alone. This is not surprising, given the
presumed interface. Electrostatic interactions between a gluta-
mate or aspartate and a lysine yield weak proton NOE cross-
peaks. Additionally, the expected hydrophobic interactions
occur in crowded regions of the spectra. We proceeded to
determine the individual solution structures of Sgt2-N and
Get5-UBL as they are in complex. Data collection for the full
assignments of the proteins in complex was performed at
37C, which reduced the severity of line-broadening effects.hors
This had the additional effect of averaging the two states of
Sgt2-N; therefore, we treated Sgt2-N as symmetric in these
calculations.
Overall, the structures of Sgt2-N and Get5-UBL while in
complex are not significantly different from the free solution
structures (Figures S5B and S5C). A few intermolecular NOEs
could be identified and were used in the calculation of the
complex structure (Figure 5D). In the absence of substantial
numbers of NOE-derived distance restraints, the structures of
complexes can be determined by molecular docking driven by
other experimental data introduced as ambiguous interaction
restraints (AIRs; Dominguez et al., 2003). We defined 14 AIRs
using the CSP and mutagenesis data, the details of which are
provided in the Extended Experimental Procedures. Moreover,
we collected residual dipolar couplings (RDCs) that restricted
rotational freedom between the models during docking. We per-
formed docking between the two separate complex structures
to generate a full model of Sgt2-N and Get5-UBL (Figure 5E).
Statistics for the structure calculation of each component, as
well as the complex, are provided in Tables S3 and S4.
The experimentally restrained docking returns a well-con-
verged structure in which the predicted binding faces interact
(Figure 5E). All of the residues that were identified to be involved
experimentally are found at the interface (Figure 5F). The inter-
face is comprised of the hydrophobic patch on Get5-UBL
(Ile81, Leu120, Val125, Gly143, and Met147) that docks against
the reciprocal patch that contains two each of Cys39 and
Val35 from the Sgt2-N dimer (Figure 5G). Additionally, Thr145
packs against one copy of Val35. The conserved lysines 79,
85, 118, 122, and 149 all make electrostatic contacts to the
charged face of Sgt2-N (two each of Asp28, Asp31, Asp38,
and Glu42).
The Complex Is a Unique UBD/UBL Interaction
Ubiquitin and UBL domains are abundant in cells and all
share common features (Winget and Mayor, 2010). Perhaps
more abundant are the different UBD motifs found in a wide
variety of frameworks (Hicke et al., 2005; Husnjak and Dikic,
2012). The combinatorial use of UBLs and UBDs results in a
wide diversity of interactions that are utilized in many different
contexts. The complex between Sgt2 and Get5 introduces a
novel interaction.
As is typical of the most commonly observed UBD interac-
tions, Sgt2-N binds at the face that contains the I44 patch
(Figures 6A and 6B). In contrast to other UBDs, Sgt2 uses a
symmetrical dimer interface to interact with its UBL. The only
other example of a UBD dimer is the swapped CUE motif found
in Vps9, which binds similarly to other CUE domains (Figure 6B;
PDB ID: 2P3Q; Prag et al., 2003). Most of the other characterized
UBDs bind primarily with a single polypeptide. A comparison
of UBD binding interfaces reveals that Sgt2 buries a relatively
large surface area (682.8A˚2; Figures 6A and 6B). The next
closest interface for a yeast UBD is that of Ufd2 bound to the
UBL of Rad23, which has an interface of 614.3A˚2 (Ha¨nzelmann
et al., 2010).
Most of the I44 patch-binding UBDs use a-helical motifs,
as does Sgt2. These proteins interact with similar groups of
residues on their respective UBLs (Figures 6C and 6D). UBLsCell Rehave a number of conserved residues around the I44 patch.
For ubiquitin, these include Leu8, Arg42, Ile44, Gly47, His68,
and Val70. These interactions are conserved on Get5 in the
interface with Sgt2 (Ile81, Lys118, Leu120, Gly123, Thr145,
and Met147). Most of these residues are similar in nature to
the canonical residues, except for Thr145, which is a histidine
in most UBLs.
Of the Sgt2/Get5 interactions, the most interesting involve
residues that are unique in the interface relative to all other
UBLs (Figures 6C and 6D). Four residues fit this description.
The most provocative, the highly conserved Ile44 of ubiquitin,
is a leucine in all Get5 homologs. Surprisingly, mutating this to
isoleucine had no effect on binding affinity (Figure 3). The second
is Gln82 in Get5, which forms a conserved hydrogen-bond
network with negative charges on Sgt2. In ubiquitin, this residue
is a threonine that likely cannot contribute to a similar network,
and in fact is pointed away from the I44 patch. Next is Lys122,
a positive charge that is conserved in Get5 homologs adjacent
to the I44 patch but is missing in other UBLs. This lysine forms
salt bridges with the conserved Asp28 and Asp31 on Sgt2. In
ubiquitin, this position is an alanine whose side chain is pointed
away from the interface. The final residue is Thr145, whose
equivalent in ubiquitin is a histidine (His68). In UBL4A, the
position is an asparagine, a more polar residue. For ubiquitin,
His68 is typically described as a component of the hydrophobic
pocket lining the edge of the I44 patch. For the Get5/Sgt2
complex, the smaller threonine is likely required to accommo-
date the tight interface.
DISCUSSION
The biogenesis of TA membrane proteins requires sorting in the
cytoplasm, followed by targeting to the membrane and then
subsequent insertion into the bilayer. For TAs destined for the
ER, the conserved GET pathway governs this process. Sgt2
and Get5 are members of the so-called yeast TRC, which
includes Get4 and HSPs. This complex is responsible for binding
and then sorting of ER-destined TAs to the targeting factor, Get3
(Wang et al., 2010). Sgt2 contains three domains (Figure 7A). The
C-terminal domain binds hydrophobic peptides with varying
affinities. Mitochondrial TA proteins are typically less polar
compared with ER-destined substrates, and it is thought that
this feature allows Sgt2 to selectively bind the latter with higher
affinity (Wang et al., 2010). The central domain contains three
TPR repeats that bind multiple classes of HSP proteins whose
structure was recently solved (Chartron et al., 2011). At the
N terminus is a homodimerization domain whose structure is
reported here. In solution, Sgt2 forms an extended dimeric
complex with the C-terminal domain moving freely at the end.
Get5 forms an obligate heterotetramer with Get4 (Figure 7A).
Get5 contains three domains: (1) an N-terminal domain, which
wraps around Get4 to form the heterodimer interface (Chang
et al., 2010; Chartron et al., 2010); (2) a C-terminal domain, which
forms a small, stable dimerization motif whose structure was
also recently solved (Chartron et al., 2012b); and (3) the central
domain, which is a novel UBL domain whose structure we
report here. The Get4/Get5 complex is also extended in solution
(Chartron et al., 2010, 2011).ports 2, 1620–1632, December 27, 2012 ª2012 The Authors 1627
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Figure 6. The Sgt2-N/Get5-UBL Complex Is a Unique UBD/UBL Interface
(A) View of the complex shown as a cartoon diagram (Sgt2-N in cyan and purple, Get5-UBL in green). Residues involved in the interface are drawn as sticks.
The interface surface area, determined using the Protein Interfaces, Surfaces, and Assemblies (PISA) tool, is indicated (Krissinel and Henrick, 2007).
(B) Representative structures of various UBD (cyan)/UBL (green) complexes that interact with the I44 patch, shown as a cartoon aligned to the Get5-UBL in (A).
Each structure is labeled with its PDB ID and the UBD group that is represented (reviewed in Hicke et al., 2005; Husnjak and Dikic, 2012). Proteins are named in
(D). Interface surface areas are indicated.
(C) View of the binding interface of representative helical UBDs. Residues at the interface are shown as sticks in (D). Get5-UBL residues Q83, L120, K122, and
T145 are colored red. Equivalent residues in other structures are also highlighted.
(D) Sequence alignment of S. cerevisiae UBL domains with human UBL4A, UBL4B, and BAG6 UBLs included. Alignment is similar to that in Figure 1C. Numbers
at the end of the sequence are percent identity to Get5. Residues that interact with various UBDs are highlighted based on the legend. Stars filled with red are
highlighted in (C).
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Figure 7. Model for the Role of the Sgt2/Get5 Complex
(A) Composite model of the Sgt2/Get4/Get5 complex based on all available structural data. In the center is the complex reported here. Sgt2 is an extended
dimer (cyan and magenta). The TPR domains extend away from each other (PDB ID: 3SZ7). The C-terminal domains, represented as rounded rectangles, are
flexible. The Get4/Get5 complex is an extended homodimer mediated by the Get5-C domain (PDB ID: 3VEJ). Get4 forms a complex with the Get5-N domain
(PDB ID: 3LKU).
(B) Model of the TRC complex in the GET pathway. Chaperones binding hydrophobic proteins rapidly bind and dissociate from the TPR domain of Sgt2. The
C-terminal domain of Sgt2 binds to ER-destined TA proteins. Sgt2 is rapidly binding and dissociating from Get4/Get5, which binds to Get3.The TA protein is
then transferred from Sgt2 to Get3.
(C) Model of themammalian TRC pathway. Chaperones and SGTA act analogously to the yeast system in (B). SGTA rapidly binds to and dissociates fromUBL4A.
The BAG6 complex then sorts substrates between the TA targeting pathway, mediated by TRC35 and TRC40 and the proteasome.The initial identification of Get4 and Get5 as bona fide
members of the GET pathway did not reveal the connection to
Sgt2 (Jonikas et al., 2009). In hindsight, this is surprising,
because previous biochemical and genetic links had been
reported (Liou et al., 2007). Subsequent studies clearly linked
the N-terminal dimerization domain of Sgt2 to the UBL domain
of Get5, solidifying the role of Sgt2 in TA targeting (Battle et al.,
2010; Chang et al., 2010; Chartron et al., 2011; Wang et al.,
2010). We previously demonstrated that although the complex
thus formed was stable enough for copurification, the interface
was sensitive to mutation (Chartron et al., 2011, 2012b). The
structures reveal a strong electrostatic component to the inter-
face between Get5 and Sgt2, which results in a complex with
fast on- and off-rates.
The affinity of Sgt2 to Get5 is remarkably high (Figure 3). In the
cell, every Get4/Get5 heterotetramer will, on average, be bound
by an Sgt2, and as one falls off, another one quickly replaces it,
consistent with experimental results (Wang et al., 2010). Our
previous work demonstrated that only a single Sgt2 dimer could
bind to theGet4/Get5 heterotetramer at one time (Chartron et al.,
2012b); therefore, Get5 has two potential binding sites for Sgt2s
that are rapidly sampling. This makes sense in a model for TA
targeting (Figure 7B), because a Get3/Get4/Get5 complex would
be stable in the cytoplasm. This complex would screen Sgt2
proteins, over multiple rounds, to find one that stably binds an
ER-destined TA protein. This interaction would lead to a handoff
of the TA to Get3, which would then be released from Get4 to
find its ER receptors. How Sgt2 finds TA proteins is a matter of
conjecture. The simplest model is that it captures free TAs in
the cytoplasm; however, it remains seductive to imagine that
the highly abundant HSPs provide at least one route into theCell Repathway. In that context, Sgt2 would bind HSPs transiently,
allowing for multiple rounds of binding to find appropriate
substrates. Once a TA protein is bound, it becomes be a stable
complex that can be found by Get4/Get5.
In metazoans, the picture becomes more complicated (Fig-
ure 7C). In addition to homologs for the yeast GET proteins, TA
targeting includes a large multidomain protein called BAG6.
BAG6 contains an N-terminal UBL domain that has features
characteristic of typical UBLs (Figure 6D) and a C-terminal
BAG domain. It is linked to TA targeting by forming a stable
complex with TRC35 and UBL4A (Mariappan et al., 2010).
TRC35 and UBL4A lack the features necessary for direct com-
plex formation in yeast (Chartron et al., 2010, 2012a) and it is
likely that they both bind BAG6 directly. The first structure solved
from this complex is the UBL domain from UBL4A (PDB ID:
2DZI), which has not been described in the literature. Although
it has yet to be experimentally demonstrated, it seems very likely
that SGTA performs a similar role in TA targeting to its yeast
counterpart (Figure 7C). The structure of the dimerization motif
of SGTA supports this, because it is a highly conserved domain,
like UBL4A-UBL, with all of the features that are important for
heterodimer formation. BAG6 has been demonstrated to be
a dimer and to form a complex with SGTA via the UBL domain
of UBL4A (Y. Ye, personal communication). This then would
mirror all of the components of the yeast system, including two
each of SGTA, UBL4A, and TRC35 (Figure 7C).
In mammalian cells, the BAG6 complex is linked to the degra-
dation of mislocalized membrane proteins and dislocated ER
products (Hessa et al., 2011; Wang et al., 2011). TA proteins
can be redirected to the degradation pathway, suggesting that
the two pathways intersect (Hessa et al., 2011). SGTA has nowports 2, 1620–1632, December 27, 2012 ª2012 The Authors 1629
been shown to be an important component for targeted degra-
dation of ERAD substrates that transiently bind hydrophobic
membrane proteins prior to handoff to BAG6 (Figure 7C; Y. Ye,
personal communication). This additional role would also
benefit from rapid sampling of SGTA to the BAG6 complex,
raising the possibility that in yeast, Sgt2 could have multiple
roles as well.
Where proteins are linked to degradation pathways, it seems
plausible that multiple UBLs divergently evolve to fill more
specific roles. This is clear for the BAG6-UBL, which has all of
the features of UBLs involved in degradation and is critical for
targeting to the proteasome (Hessa et al., 2011; Wang et al.,
2011). The Get5/UBL4A UBL represents a unique class of
UBLs with features that clearly distinguish them from other
UBLs (Figure 6). In fact, when the conserved histidine of the
BAG6-UBL is converted to an asparagine, it completely loses
its ability to bind to standard UBDs (Y. Ye, personal communica-
tion). A similar effect is not seen when the conserved Leu120
is replaced by an isoleucine, although this could be a change
to prevent other UBDs from binding Get5.
Sgt2 and SGTA are UBDs that have very specific binding
partners. An interface dominated by electrostatics is unique
among UBL/UBD complexes. This presumably allows high-
affinity, rapid binding while strongly rejecting unfavorable
interactions with other UBLs and UBDs. One interesting side
note is that in mammals, both UBL4A and SGTA have tissue-
specific isoforms: Ubl4B and SGTB (Tobaben et al., 2003;
Yang et al., 2007). Although SGTA and SGTB have similar
conserved sequence elements, UBL4B is missing a number of
the residues that likely form the SGTA/UBL4A interface (Fig-
ure 6D). This suggests that it may have lower affinity or perhaps
an unknown UBD.
In this report, we demonstrate a conserved UBD/UBL interac-
tion that is critical for TA targeting. The complex is in a dynamic
equilibrium that allows for rapid sampling of the various compo-
nents. This attribute is likely essential for the various roles that
Sgt2 homologs must play. This work opens the door to under-
standing the steps of target selection and discrimination that
are required for a regulated process. The finer details of the
process of TA targeting continue to be resolved at a rapid
pace; however, each new insight leads to unexpected elabora-
tions. With the recent link to regulated proteolysis, TA targeting
is becoming part of the greater picture of homeostasis in the cell.
EXPERIMENTAL PROCEDURES
Solution NMR Structure Determination
Sgt2-N and Get5-UBL were overexpressed and purified from Escherichia coli.
Chemical shift assignments were made using uniformly 13C/15N-labeled
samples. Data were collected on a Varian Inova 600 MHz spectrometer with
a triple-resonance probe or a Bruker Avance 800 MHz with a TCI cryoprobe.
Structures were calculated using NOE-derived distance restraints.
Double-labeled proteins were mixed with excesses of natural abundance
protein. The asymmetrically labeled complexes were then purified by size
exclusion chromatography. Chemical shifts were assigned and structures
were calculated separately for each protein in the complex. CSP and muta-
genesis data were used to define AIRs that were used along with 14 inter-
molecular NOE distance restraints and RDCs to calculate the complete
structure of the complex (Dominguez et al., 2003). Details of the solution
NMR experiments are provided in Extended Experimental Procedures.1630 Cell Reports 2, 1620–1632, December 27, 2012 ª2012 The AutDetermination of SGTA-N and Get5-UBL Crystal Structures
Human SGTA-N and UBL4A-UBL were coexpressed in E. coli and purified by
affinity and size exclusion chromatography. All crystallizations were performed
by the vapor diffusion technique. Diffraction data were collected at beamline
12-2 at the Stanford Synchrotron Radiation Lightsource (SSRL). Phases
were recovered by molecular replacement using the solution NMR structures
presented here. Additional details regarding crystal growth, data collection,
and model refinement are provided in Extended Experimental Procedures.
ITC
Data were collected with aMicroCal iTC-200 calorimeter. Details of the sample
preparation are provided in Extended Experimental Procedures. Proteins in
the sample cell were at 30–100 mM, and proteins in the injection syringe
were concentrated to 800–1,000 mM. For each experiment, an initial injection
of 0.4 ml was followed by 19 injections of 2 ml each. The cell was allowed to
equilibrate for 120 s between titrations. Data were processed using Origin
v7.0 (OriginLab) software with a single-site model.
SPR
Sample and running conditions are described in Extended Experimental
Procedures. Data were collected using a Biacore T-100 system upgraded
to T-200 sensitivity (GE Healthcare). Mouse anti-pentahistidine antibody
(QIAGEN) was covalently linked to a CM5 dextran chip using standard amide
coupling chemistry. Hexahistidine-tagged Get5-UBL (WT or mutants) or
Get5-UBL-C were then immobilized. An equilibrium binding analysis was
performed using BIAevaluation software (GE Healthcare). A kinetic analysis
between WT Sgt2-N and Get5-UBL was performed using Kaleidagraph
(Synergy Software). The slope values ks at each concentration were deter-
mined by linear regression fitting of the association phase to the integrated
first-order rate equation. Values of ks were plotted against concentration,
and the association rate kon was determined from the linear fit to Equation 1:
ks = kon3 ½Sgt2-N+ koff: (Equation 1)
This fit results in a koff of 3.9 s
1, but because koff may not accurately be
determined by this method (Karlsson et al., 1991), we additionally estimated
it using the equilibrium dissociation constant as the ratio of koff to kon.
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